Avantor AVTR Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Bioscience & Medtech Products | $431.4M— | —— | —— | —— | $426.4M— | |
| VWR Distribution & Services | $1.15B— | —— | —— | —— | $1.16B— | |
| Adjusted Operating Income by Business | ||||||
| Bioscience & Medtech Products | $102.7M— | —— | —— | —— | $114.5M— | |
| VWR Distribution & Services | $105.4M— | —— | —— | —— | $147.9M— | |
| Adjusted operating expenses by Business | ||||||
| Bioscience & Medtech Products | $102M— | —— | —— | —— | $96.5M— | |
| VWR Distribution & Services | $190.7M— | —— | —— | —— | $176.1M— | |
| Adjusted cost of goods and services sold by Business | ||||||
| Bioscience & Medtech Products | $226.7M— | —— | —— | —— | $215.4M— | |
| VWR Distribution & Services | $853.9M— | —— | —— | —— | $831M— | |
| D&A by Business | ||||||
| Bioscience & Medtech Products | $49.2M— | —— | —— | —— | $43.8M— | |
| VWR Distribution & Services | $55.8M— | —— | —— | —— | $55.9M— | |
| Net Sales by Product | ||||||
| Proprietary | $833.3M-4.2% | $869.8M+1.7% | $855.6M-4.3% | $893.8M+7.7% | $829.7M-7.5% | |
| Third-party | $748.1M-5.8% | $793.8M+3.3% | $768.2M-2.7% | $789.6M+5.0% | $751.7M-4.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Avantor break its business down?
- Avantor (AVTR) reports net sales by business across 2 parts — Bioscience & Medtech Products and VWR Distribution & Services. Each is extracted from the segment footnotes and tracked over time.
- Where does Avantor's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Avantor's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
